Explaining variation in the uptake of HPV vaccination in England

BMC Public Health

Volumn 11, Issue , 2011, Pages

  Kumar, Varun M ^a   Whynes, David K ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN PAPILLOMAVIRUS VACCINE, L1 TYPE 16, 18; WART VIRUS VACCINE;

ADOLESCENT; ARTICLE; ATTITUDE TO HEALTH; CHILD; COHORT ANALYSIS; EARLY DIAGNOSIS; ETHNIC GROUP; ETHNOLOGY; FEMALE; HEALTH CARE QUALITY; HUMAN; PREVENTIVE HEALTH SERVICE; PRIMARY HEALTH CARE; PUBLIC HEALTH; SOCIOECONOMICS; STATISTICS; UNITED KINGDOM; UTERINE CERVIX TUMOR; UTILIZATION REVIEW; VACCINATION;

ADOLESCENT; ATTITUDE TO HEALTH; CHILD; COHORT STUDIES; EARLY DETECTION OF CANCER; ENGLAND; ETHNIC GROUPS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; NATIONAL HEALTH PROGRAMS; PAPILLOMAVIRUS VACCINES; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 79953076449     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-11-172     Document Type: Article

References (35)

1. Cuzick J, Castanon A, Sasieni P: Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. British Journal of Cancer 2010, 102:933-939.
2. Hall AJ: The United Kingdom Joint Committee on Vaccination and Immunisation. Vaccine 2010, 28S:A54-A57.
3. Jit M, Choi YH, Edmunds WJ: Economic evaluation of human papillomavirus vaccination in the United Kingdom. British Medical Journal 2008, 337:a769.
4. Sheridan A, White JL, Barlow T, Soldan K: Annual HPV vaccine uptake in England: 2008/2009. Department of Health (Gateway reference 13374), London; 2010.
5. Marlow LAV, Waller J, Wardle J: Sociodemographic predictors of HPV testing and vaccination acceptability: results from a population-representative sample of British women. Journal of Medical Screening 2008, 15:91-96.
6. Marlow LAV, Wardle J, Forster AS, Waller J: Ethnic differences in human papillomavirus awareness and vaccine acceptability. Journal of Epidemiology and Community Health 2009, 63:1010-1015.
7. Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, McCann R: Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. British Medical Journal 2008, 336:1056-1058. (Pubitemid 351692248)
8. Roberts SA, Brabin L, Stretch R, Baxter D, Elton P, Kitchener H, McCann R: Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiology and Infection 2011, 139(3):400-405.
9. Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, Patrick DM, Naus M: A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Medicine 2010, 7(5):e1000270.
10. Rondy M, van Lier A, van de Kassteele J, Rust L, de Melker H: Determinants for HPV vaccine uptake in the Netherlands: a multilevel study. Vaccine 2010, 28:2070-2075.
11. Chao C, Slezak JM, Coleman KJ, Jacobsen SJ: Papanícolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. American Journal of Public Health 2009, 99(6):1137-1142.
12. Chao C, Velicer C, Slezak JM, Jacobsen SJ: Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology 2010, 171(3):357-367.
13. Noble M, McLennan D, Wilkinson K, Whitworth A, Barnes H, Dibben C: The English indices of deprivation 2007. Department for Communities and Local Government, HMSO, London; 2008.
14. NHS Information Centre-Workforce and Facilities: Cervical screening programme, England 2008-09. Health and Social Care Information Centre, Leeds; 2009.
15. NHS Information Centre-Workforce and Facilities: NHS immunisation statistics, England 2008-09. The Health and Social Care Information Centre, Leeds; 2009.
16. National Chlamydia Screening Programme Team: NHS vital signs 2008/9. Health Protection Agency; 2009 [http://www.chlamydiascreening.nhs.uk/ps/assets/ pdfs/data/VSI-PCT/Vital-Signs%20-PCT-%20April%2008-Mar%2009-Masked.pdf].
17. Office of National Statistics: Population estimates by ethnic group. 2010 [http://www.statistics.gov.uk/statbase/product.asp?vlnk=14238], TablesEE1-EE6-PCO2007.xls.
18. NHS Information Centre: Prescribing Support Unit: Quality and Outcomes Framework achievement data 2008/09. 2009 [http://www.ic.nhs.uk/statistics-and- data-collections/supporting-information/audits-and-performance/ the-quality-and-outcomes-framework/qof-2008/09/data-tables/pct-level-data- tables].
19. Tickner S, Leman PJ, Woodcock A: The Immunisation Beliefs and Intentions Measure (IBIM): Predicting parents' intentions to immunise preschool children. Vaccine 2010, 28:3350-3362.
20. Pearce A, Elliman D, Law C, Bedford H, Millennium Cohort Study Child Health Group: Does primary immunisation status predict MMR uptake? Archives of Disease in Childhood 2009, 94:49-51.
21. Wallace LA, Bramley JC, Ahmed S, Duff R, Hutchinson SJ, Carman WF, Kitchin NRE, Goldberg DJ: Determinants of universal adolescent hepatitis B vaccine uptake. Archives of Disease in Childhood 2004, 89:1041-1042.
22. Wright JA, Polack C: Understanding variation in measles-mumps-rubella immunization coverage-a population-based study. European Journal of Public Health 2005, 16(2):137-142.
23. Samad L, Tate AR, Dezateux C, Peckham C, Butler N, Bedford H, Millennium Cohort Study Child Health Group: Differences in risk factors for partial and no immunisation in the first year of life: prospective cohort study. British Medical Journal 2006, 332:1312-1314.
24. Weller DP, Campbell C: Uptake in cancer screening programmes: a priority in cancer control. British Journal of Cancer 2009, 101:S55-S59.
25. Webb R, Richardson J, Esmail A, Pickles A: Uptake for cervical screening by ethnicity and place-of-birth: a population-based cross-sectional study. Journal of Public Health 2004, 26(3):293-296. (Pubitemid 39312935)
26. Willoughby BJ, Faulkner K, Stamp EC, Whitaker CJ: A descriptive study of the decline in cervical screening coverage rates in the North East and Yorkshire and the Humber regions of the UK from 1995 to 2005. Journal of Public Health 2006, 28(4):355-360.
27. Moser K, Patnick J, Beral V: Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data. British Medical Journal 2009, 338:b2025.
28. Ashworth M, Armstrong D: The relationship between general practice characteristics and quality of care: a national survey of quality indicators used in the UK Quality and Outcomes Framework, 2004-5. BMC Family Practice 2006, 7:68.
29. Johnson SA, Simms I, Sheringham J, Bickler G, Bennett CM, Hall R, Cassell JA: The implementation of chlamydia screening: a cross-sectional study in the South East of England. Sexually Transmitted Infections 2010, 86:217-221.
30. Baker D, Garrow A, Shiels C: Inequalities in immunisation and breast feeding in an ethnically diverse urban area: cross-sectional study in Manchester, UK. Journal of Epidemiology and Community Health 2010.
31. Hilton S, Hunt K, Langan M, Bedford H, Petticrew M: Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005-2008). Social Science and Medicine 2010, 70(6):942-950.
32. Brown ECF, Little P, Leydon GM: Communication challenges of HPV vaccination. Family Practice 2010, 27:224-229.
33. Puig-Junoy J, Lopez-Valcarcel BG: Economic evaluations of massive HPV vaccination: within-study and between study variations in incremental cost per QALY gained. Preventive Medicine 2009, 48:444-448.
34. Haas M, Ashton T, Blum K, Christiansen T, Conis E, Crivelli L, Lim MK, Lisac M, MacAdam M, Schlette S: Drugs, sex, money and power: an HPV vaccine case study. Health Policy 2009, 92(2-3):288-295.
35. Paul-Ebhohimhen V, Huc S, Tissington H, Oates K, Cameron Stark C: HPV vaccination: vaccine acceptance, side effects and screening intentions. Community Practitioner 2010, 83(6):30-33.